Trimedyne (TMED) Stock Price, News & Analysis

Company Overview

Trimedyne, Inc. manufactures and sells lasers, and disposable and reusable fiber-optic laser devices for use in the medical field. It offers lasers, fibers, needles, and switch tips for use in orthopedics, urology, ear and nose surgery, throat surgery, gynecology, gastrointestinal surgery, general surgery, and other medical specialties. The company also provides 80 watt and 30 watt holmium lasers, and side firing laser needles to treat herniated or ruptured spinal discs. In addition, it engages in the provision of services, and rental of lasers and other medical equipment to hospitals and surgery centers on a fee-per-case basis. The company operates in Asia, Europe, Latin America, the Middle East, Australia, and internationally. It markets its products through commission sales representatives in the United States and independent distributors internationally. Trimedyne, Inc. was founded in 1980 and is based in Irvine, California.

Key Stats

• Today's Range: $28.02 to $28.12
• 50-Day Range: $23.61 to $28.22
• 52-Week Range: $23.46 to $28.37
• Volume: 1,388 shs
• Average Volume: 1,993 shs
• Market Capitalization: $14.06 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TMED Stock Analysis - Frequently Asked Questions

How have TMED shares performed this year?

Trimedyne's stock was trading at $4.25 at the start of the year. Since then, TMED shares have increased by 559.5% and is now trading at $28.03.

How were Trimedyne's earnings last quarter?

Trimedyne, Inc. (OTCMKTS:TMED) released its quarterly earnings results on Tuesday, February, 20th. The technology company reported $0.70 EPS for the quarter. The technology company earned $1.53 million during the quarter.

How do I buy shares of Trimedyne?

Shares of TMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Trimedyne own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Trimedyne investors own include Aflac (AFL), Incyte (INCY), Martin Marietta Materials (MLM), National Fuel Gas (NFG), PDC Energy (PDCE), Snap (SNAP) and Agilent Technologies (A).

Company Calendar

• Last Earnings: 2/20/2018
• Today: 10/15/2025
• Fiscal Year End: 9/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Computer and Technology
• Industry: Electromedical equipment
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:TMED
• CIK: 357001
• Web: www.trimedyne.com
• Phone: 949-951-3800
• Fax: 949-855-8206
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 500,000
• Free Float: N/A
• Market Cap: $14.02 million
• Optionable: Not Optionable
• Beta: N/A